Gottesman, M H <br/><br/>
Interferon beta-1b (betaseron/betaferon) is well tolerated at a dose of 500 microg: interferon dose escalation assessment of safety (IDEAS).  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Jun 2006 
 - 271-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-4585 
<br/><br/><label>Standard No.: </label>10.1191/135248506ms1261oa  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Antibodies--blood<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon beta-1b<br/>Interferon-beta--administration & dosage<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Chronic Progressive--drug therapy<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Neutralization Tests<br/>Treatment Outcome